BRENTUXIMAB VEDOTIN
brentuximab vedotin 50 mg injection, 1 vial
BRENTUXIMAB VEDOTIN (15098P)
15098P
Manner of administration:Injection
Restriction
Indication: Stage III or IV CD30 positive Hodgkin lymphoma
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 120 mg | # of repeats: 11 | DPMA: $13,357.98 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Adcetris
(brentuximab vedotin 50 mg injection, 1 vial)
|
||||